- In The Money: eCommerce, DTC and CPG
- Posts
- Perelel’s Big Raise, Topgolf’s Reset, and What Investors Really Want
Perelel’s Big Raise, Topgolf’s Reset, and What Investors Really Want
Perelel’s growth, Function’s rocketship membership model, Topgolf’s reset, and what Willow Growth says founders still get wrong.
Perelel Raises $27M and Shows the New Playbook for Winning in Women’s Wellness
Perelel announced a $27M growth round this week, led by Prelude Growth Partners with participation from Unilever Ventures, Willow Growth, and Selva. It’s an impressive raise in one of consumer’s most competitive categories: supplements.
What’s more impressive is how they’ve built the business.
Life-stage specificity instead of generic wellness.
Where most vitamin brands rely on catch-all formulations, Perelel built its architecture around women’s biological milestones: conception, each trimester, postpartum, and perimenopause. That segmentation creates trust, pricing power, and retention.
Clinical credibility as moat.
Doctor-founded and doctor-designed formulations set Perelel apart from the marketing-heavy brands that crowd the space.
A long, predictable customer lifecycle.
Done well, the prenatal → postpartum → hormone-health journey spans years, not months. That shows up in LTV.
Disciplined omnichannel expansion.
Instead of rushing into retail, Perelel validated retention and unit economics first — then expanded into Target, Whole Foods, and prestige channels.
In a category where many brands plateau early, Perelel is showing what thoughtful category design actually looks like.
Function Health Raises $298M at a $2.5B Valuation, One of the Fastest-Growing Consumer Brands
Function Health’s $298M raise (at a $2.5B valuation) positions it as one of the most important emerging companies in consumer health.
The model:
A membership that gives users 100+ biomarker labs twice per year, with all health data integrated into an AI-driven “Medical Intelligence” platform.
The metric that stands out:
Function reports “hundreds of thousands” of members. Even if that means ~250,000 members paying ~$499 annually, revenue could already exceed $125M for a business launched in 2022.
Why investors are leaning in:
Recurring revenue in a category that’s never had it.
Labs are typically episodic; Function makes them subscription-based.
A proprietary data advantage.
The company is building a longitudinal model trained on labs, imaging, physician notes, and multi-year member histories; an AI moat that strengthens with every test.
A platform that keeps expanding.
Labs → imaging → insights → longitudinal care. Each layer widens TAM and deepens retention.
Function is shaping up to be one of the most consequential consumer-health companies of the decade.
Topgolf Resets: Leonard Green Acquires 60% at a $1.1B Valuation
Topgolf Callaway Brands announced it will sell 60% of Topgolf + Toptracer to Leonard Green for $770M, valuing the business at ~$1.1B; roughly half the implied valuation when Callaway acquired it in 2020.
It’s a meaningful reset for one of the most ambitious experiential concepts of the 2010s.
Once fueled by hundreds of millions in private capital, Topgolf was acquired by Callaway for ~$2B with the vision of creating a vertically integrated golf ecosystem; spanning equipment, venues, and technology.
But rising venue capex, debt load, and margin pressure challenged the story. Public-market investors never embraced the “golf conglomerate” model, and MODG traded at a persistent discount.
The new structure gives Callaway deleveraging room, puts Topgolf under a specialist operator in Leonard Green, and preserves 40% ownership for future upside.
It’s a pragmatic reset for an asset that still carries meaningful consumer affinity.
🎙 Podcast Highlight: What It Takes to Raise Capital in 2025. Insights from Willow Growth’s Amanda Schutzbank
On this week’s episode of In The Money, I spoke with Amanda Schutzbank, Co-Founder & Managing Partner at Willow Growth Partners, one of the most respected early-stage firms in consumer.
If you’re building a consumer brand or raising capital in 2025, this conversation is a roadmap.
We cover:
• Why fundraising looks nothing like 2021, and won’t again
• The biggest misconception founders still have about raising growth capital
• Why product → distribution → narrative fit now matters more than speed
• The traits Willow sees in founders who scale from $0 → $50M+
• How to build investor alignment that lasts multiple cycles
• Which categories feel overcrowded, and which are opening up
• Her #1 piece of advice for founders heading into 2026
It’s one of the most practical conversations we’ve had this year on what “good” looks like in the current capital environment.
🎧 Watch on YouTube, listen on Spotify.
That’s it for this week.
If you liked this issue, forward to a friend who obsesses over brand strategy, capital flows, or exit timing.
In the Money – following the flow of capital in consumer
P.S. We love talking to brands interested in exiting in the next 3-18 months. If you know of any brands interested in exiting, or any firms trying to help port cos manage turnarounds, we'd love to share a POV.
fan [at] thehedgehogcompany.com
